Atlas Trials

Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma

Clinical trial NCT02061670 · COMPLETED

Trial details

NCT number
NCT02061670
Sponsor
Circassia Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Seasonal Allergic RhinitisAsthma
Start date
2014-01-01
Primary completion
2014-10-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.